Research Article
The Evolving Genotypic Profile of HIV-1 Mutations Related to Antiretroviral Treatment in the North Region of Brazil
Table 1
Characteristics of patients failing ARV.
| Characteristics | Total (377) |
| Age in years | | Mean (range) | 40.73 (±9.43) | Gender | | Male | 250 (66.3%) | CD4+ count (cells/µL) | | Mean (range) | 199.93 (±173,36) | HIV RNA level | | Mean (range) | 5.005 (±5,509) | Number of therapeutic failures | | First treatment | 91 (24.2%) | Second treatment | 85 (22.5%) | Multiexperienced | 201 (53.3%) | ARVs before genotyping | | NRTIs + NNRTIs | 177 (46.9%) | NRTIs + PI/r | 131 (34.8%) | NRTIs + PI | 53 (14.1%) | NRTIs + NNRTIs + PI/r | 12 (3.2%) | NRTIs + double-boosted PI | 2 (0.5%) | NRTIs only | 2 (0.5%) |
|
|
Antiretrovirals, ARV; nucleoside reverse transcriptase inhibitors, NRTIs; nonnucleoside reverse transcriptase inhibitors, NNRTIs; protease inhibitors, PI; boosted protease inhibitors, PI/r.
|